Filing Details

Accession Number:
0001181431-11-011420
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-18 13:44:54
Reporting Period:
2011-01-21
Filing Date:
2011-02-18
Accepted Time:
2011-02-18 13:44:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1036968 Diadexus Inc. DDXS Pharmaceutical Preparations (2834) 943236309
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134270 Burrill & Co Llc One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
1198177 Steven Burrill One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
1204411 Burrill Life Sciences Capital Fund Lp One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
1397090 Burrill & Co (Indiana Gp), Llc One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
1397091 Burrill Indiana Life Sciences Capital Fund, L.p. One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
1397093 Burrill & Co (Life Sciences Gp), Llc One Embarcadero Center, Suite 2700
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-21 55,500 $0.40 5,355,387 No 4 P Direct
Common Stock Acquisiton 2011-01-24 100,000 $0.40 5,455,387 No 4 P Direct
Common Stock Acquisiton 2011-01-28 13,000 $0.38 5,468,387 No 4 P Direct
Common Stock Acquisiton 2011-02-01 15,300 $0.39 5,483,687 No 4 P Direct
Common Stock Acquisiton 2011-02-02 15,000 $0.40 5,498,687 No 4 P Direct
Common Stock Acquisiton 2011-02-03 15,287 $0.40 5,513,974 No 4 P Direct
Common Stock Acquisiton 2011-02-07 5,000 $0.40 5,518,974 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The securities ("Securities") constitute the common stock of diaDexus, Inc. (the "Company") directly held by Burrill Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BLSCF"), and by Burrill Indiana Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BILSCF") in the amounts set forth in footnotes 3 through 9. BLSCF and BILSCF operate together as if they are a single fund. All Securities listed in this Form 4 also represent shares indirectly held by BLSGP, BIGP, Burrill and BLLC, as each are defined below.
  2. Burrill & Company (Life Sciences GP), LLC ("BLSGP") and Burrill & Company (Indiana GP), LLC ("BIGP") are the general partners of BLSCF and BILSCF, respectively. G. Steven Burrill ("Burrill") controls Burrill & Company LLC ("BCLLC"), which controls BLSGP and BIGP; thus Burrill ultimately holds the power to vote and dispose of the equity interests of both BLSGP and BIGP. BLSCF, BILSCF, BLSGP, BIGP, BCLLC, and Burrill (the "Reporting Persons") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Each Reporting Person disclaims beneficial ownership of the Securities, except to the extent of its pecuniary interest therein.
  3. Represent 53,087 shares directly held by BLSCF, 2,413 shares directly held by BILSCF, and 55,500 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  4. Represent 95,652 shares directly held by BLSCF, 4,348 shares directly held by BILSCF, and 100,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  5. Represent 12,435 shares directly held by BLSCF, 565 shares directly held by BILSCF, and 13,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  6. Represent 14,635 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,300 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  7. Represent 14,348 shares directly held by BLSCF, 652 shares directly held by BILSCF, and 15,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  8. Represent 14,622 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,287 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
  9. Represent 4,783 shares directly held by BLSCF, 217 shares directly held by BILSCF, and 5,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.